PT1077942E - Derivados de carboxamida substituidos com carboxilo como antagonistas do receptor de taquiquinina - Google Patents
Derivados de carboxamida substituidos com carboxilo como antagonistas do receptor de taquiquininaInfo
- Publication number
- PT1077942E PT1077942E PT99920201T PT99920201T PT1077942E PT 1077942 E PT1077942 E PT 1077942E PT 99920201 T PT99920201 T PT 99920201T PT 99920201 T PT99920201 T PT 99920201T PT 1077942 E PT1077942 E PT 1077942E
- Authority
- PT
- Portugal
- Prior art keywords
- taquiquinine
- antagonists
- carboxyl
- receptor
- derivatives substituted
- Prior art date
Links
- -1 CARBOXYL Chemical group 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 150000007942 carboxylates Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7961098A | 1998-05-15 | 1998-05-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1077942E true PT1077942E (pt) | 2005-03-31 |
Family
ID=22151630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT99920201T PT1077942E (pt) | 1998-05-15 | 1999-04-30 | Derivados de carboxamida substituidos com carboxilo como antagonistas do receptor de taquiquinina |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1077942B1 (enExample) |
| JP (1) | JP4132671B2 (enExample) |
| KR (1) | KR20010043598A (enExample) |
| CN (1) | CN1136191C (enExample) |
| AR (1) | AR015298A1 (enExample) |
| AT (1) | ATE286882T1 (enExample) |
| AU (1) | AU743487B2 (enExample) |
| DE (1) | DE69923173T2 (enExample) |
| DK (1) | DK200001669A (enExample) |
| ES (1) | ES2233042T3 (enExample) |
| HU (1) | HUP0102531A3 (enExample) |
| IL (1) | IL139262A (enExample) |
| MX (1) | MXPA00011204A (enExample) |
| NO (1) | NO319766B1 (enExample) |
| NZ (1) | NZ507432A (enExample) |
| PT (1) | PT1077942E (enExample) |
| SI (1) | SI1077942T1 (enExample) |
| TW (1) | TWI228122B (enExample) |
| WO (1) | WO1999059972A1 (enExample) |
| ZA (1) | ZA200006606B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020082421A1 (en) * | 2000-09-14 | 2002-06-27 | Abdel-Magid Ahmed F. | Novel solid salt forms of N-[2-[4-[2-(1- methylethoxy)phenyl]-1-piperazinyl]-2-oxo-1piperidineacetamide |
| US20060128752A1 (en) * | 2002-07-03 | 2006-06-15 | Giuseppe Alvaro | Chemical compounds |
| US8093268B2 (en) | 2007-01-24 | 2012-01-10 | Glaxo Group Limited | Pharmaceutical compositions comprising 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2S-phenylpiperidin-3S-yl-) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9502644D0 (en) * | 1995-02-10 | 1995-03-29 | Zeneca Ltd | Heterocyclic derivatives |
| FR2738245B1 (fr) * | 1995-08-28 | 1997-11-21 | Sanofi Sa | Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant |
-
1999
- 1999-04-30 AU AU37756/99A patent/AU743487B2/en not_active Ceased
- 1999-04-30 DE DE69923173T patent/DE69923173T2/de not_active Expired - Lifetime
- 1999-04-30 IL IL13926299A patent/IL139262A/xx not_active IP Right Cessation
- 1999-04-30 HU HU0102531A patent/HUP0102531A3/hu unknown
- 1999-04-30 NZ NZ507432A patent/NZ507432A/en unknown
- 1999-04-30 AT AT99920201T patent/ATE286882T1/de not_active IP Right Cessation
- 1999-04-30 WO PCT/US1999/009450 patent/WO1999059972A1/en not_active Ceased
- 1999-04-30 EP EP99920201A patent/EP1077942B1/en not_active Expired - Lifetime
- 1999-04-30 JP JP2000549591A patent/JP4132671B2/ja not_active Expired - Lifetime
- 1999-04-30 MX MXPA00011204A patent/MXPA00011204A/es not_active IP Right Cessation
- 1999-04-30 KR KR1020007012743A patent/KR20010043598A/ko not_active Ceased
- 1999-04-30 CN CNB998061891A patent/CN1136191C/zh not_active Expired - Fee Related
- 1999-04-30 SI SI9930752T patent/SI1077942T1/xx unknown
- 1999-04-30 PT PT99920201T patent/PT1077942E/pt unknown
- 1999-04-30 ES ES99920201T patent/ES2233042T3/es not_active Expired - Lifetime
- 1999-05-13 AR ARP990102258A patent/AR015298A1/es active IP Right Grant
- 1999-05-24 TW TW088107935A patent/TWI228122B/zh not_active IP Right Cessation
-
2000
- 2000-11-09 DK DK200001669A patent/DK200001669A/da not_active Application Discontinuation
- 2000-11-14 NO NO20005756A patent/NO319766B1/no unknown
- 2000-11-14 ZA ZA200006606A patent/ZA200006606B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200006606B (en) | 2002-02-14 |
| DE69923173D1 (en) | 2005-02-17 |
| TWI228122B (en) | 2005-02-21 |
| IL139262A0 (en) | 2001-11-25 |
| MXPA00011204A (es) | 2003-04-22 |
| NO20005756L (no) | 2001-01-12 |
| NO319766B1 (no) | 2005-09-12 |
| AU743487B2 (en) | 2002-01-24 |
| JP4132671B2 (ja) | 2008-08-13 |
| ATE286882T1 (de) | 2005-01-15 |
| EP1077942B1 (en) | 2005-01-12 |
| CN1301253A (zh) | 2001-06-27 |
| ES2233042T3 (es) | 2005-06-01 |
| EP1077942A1 (en) | 2001-02-28 |
| SI1077942T1 (en) | 2005-06-30 |
| HUP0102531A2 (hu) | 2001-11-28 |
| KR20010043598A (ko) | 2001-05-25 |
| AR015298A1 (es) | 2001-04-18 |
| NO20005756D0 (no) | 2000-11-14 |
| NZ507432A (en) | 2003-08-29 |
| AU3775699A (en) | 1999-12-06 |
| HUP0102531A3 (en) | 2003-01-28 |
| DK200001669A (da) | 2000-11-09 |
| DE69923173T2 (de) | 2006-01-05 |
| CN1136191C (zh) | 2004-01-28 |
| IL139262A (en) | 2005-06-19 |
| JP2002515487A (ja) | 2002-05-28 |
| WO1999059972A1 (en) | 1999-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69928945D1 (de) | 4,4-biarylpiperidinederivate mit opioid-receptor-wirkung | |
| BR9707391A (pt) | Pirazolpirimidinas como antagonistas de receptor de crf | |
| PT804419E (pt) | Derivados de quinolina como antagonistas do receptor de taquiquinina nk3 | |
| ATE280157T1 (de) | 4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii | |
| PT1349839E (pt) | Derivados de feniletenilo ou feniletinilo como antagonistas do receptor de glutamato | |
| PT1224174E (pt) | Derivados de benzodiazepina como antagonistas do receptor metabotropico do glutamato | |
| BR9709072A (pt) | Derivados indol úteis como antagonistas dos receptores endotelina | |
| BR9610823A (pt) | Derivados de pirimidina como antagonistas do receptor | |
| PT1224175E (pt) | Derivados de benzodiazepina como antagonistas do receptor de glutamato metabotropico | |
| NO20012411D0 (no) | Pyrrolidin-derivater-CCR-3-reseptorantagonister | |
| DE69734833D1 (de) | Vitronektin rezeptor antagonisten | |
| EP0885205A4 (en) | Fibrinogen Receptor Antagonists | |
| PL356990A1 (en) | Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists | |
| ID24726A (id) | Antagonis-antagonis reseptor trombin | |
| ATE272632T1 (de) | Muskarin-rezeptor antagonisten | |
| NO20015779L (no) | Bradykinin-reseptorantagonister | |
| DE69939053D1 (de) | 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives als muskarin-rezeptor antagonisten | |
| PT1027342E (pt) | Derivados de ciclopentenos uteis como antagonistas do receptor da motilina | |
| ID26223A (id) | Antagonis reseptor vitronektin | |
| PT1163264E (pt) | Novos antagonistas de lhrh com propriedades de solubilidade melhoradas | |
| BR9707733A (pt) | Antagonistas de receptores muscarinicos oxa-e-tia-diazol | |
| ID24162A (id) | Antagonis-antagonis reseptor vitronektin | |
| EP0929218A4 (en) | P2Y RECEPTOR ANTAGONISTS | |
| PT1200400E (pt) | Derivados de pirrolidino-2,3,4-trion-3-oxina substituidas com eficacia como antagonistas do receptor nmda | |
| PT1216250E (pt) | Derivados propilicos substituidos de tienoisoxazolil- e tienilpirrazolil-fenoxi uteis como antagonistas d4 |